12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      DNA replication is highly resilient and persistent under the challenge of mild replication stress

      brief-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          Mitotic DNA synthesis (MiDAS) has been proposed to restart DNA synthesis during mitosis because of replication fork stalling in late interphase caused by mild replication stress (RS). Contrary to this proposal, we find that cells exposed to mild RS in fact maintain continued DNA replication throughout G2 and during G2-M transition in RAD51- and RAD52-dependent manners. Persistent DNA synthesis is necessary to resolve replication intermediates accumulated in G2 and disengage an ATR-imposed block to mitotic entry. Because of its continual nature, DNA synthesis at very late replication sites can overlap with chromosome condensation, generating the phenomenon of mitotic DNA synthesis. Unexpectedly, we find that the commonly used CDK1 inhibitor RO3306 interferes with replication to preclude detection of G2 DNA synthesis, leading to the impression of a mitosis-driven response. Our study reveals the importance of persistent DNA replication and checkpoint control to lessen the risk for severe genome under-replication under mild RS.

          Graphical abstract

          Highlights

          • DNA synthesis persists during G2-M transition to counteract replication stress (RS)

          • RAD51/RAD52-mediated HR pathways facilitate the continuation of G2-M DNA synthesis

          • Continued G2 DNA synthesis relieves RS-induced G2/M checkpoint for mitotic entry

          • RO3306, but not CDK1 inhibition, non-specifically interferes with DNA synthesis

          Abstract

          Contrary to the MiDAS model, in which stressed replication forks fail to proceed in late interphase unless mitosis is initiated, Mocanu et al. reveal that cells maintain continued DNA synthesis from S-phase to early mitosis to minimize genome under-replication. This response is also essential to lessen persistent ATR-mediated G2/M checkpoint activation.

          Related collections

          Most cited references37

          • Record: found
          • Abstract: found
          • Article: not found

          DNA double-strand break repair-pathway choice in somatic mammalian cells

          The major pathways of DNA double strand break (DSB) repair have key roles in suppressing genomic instability. However, if deployed in an inappropriate cellular context, these same repair functions can mediate chromosome rearrangements that underlie various human diseases, ranging from developmental disorders to cancer. Two major mechanisms of DSB repair predominate in mammalian cells, namely homologous recombination and non-homologous end joining. In this Review, we outline a ‘decision tree’ of DSB repair pathway choice in somatic mammalian cells, and consider how DSB repair dysfunction can lead to genomic instability. Stalled or broken replication forks present a distinctive challenge to the DSB repair system. Emerging evidence suggests that the ‘rules’ governing stalled fork repair pathway choice differ from those that operate at a conventional DSB.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1.

            CDK1 is a nonredundant cyclin-dependent kinase (CDK) with an essential role in mitosis, but its multiple functions still are poorly understood at a molecular level. Here we identify a selective small-molecule inhibitor of CDK1 that reversibly arrests human cells at the G(2)/M border of the cell cycle and allows for effective cell synchronization in early mitosis. Inhibition of CDK1 during cell division revealed that its activity is necessary and sufficient for maintaining the mitotic state of the cells, preventing replication origin licensing and premature cytokinesis. Although CDK1 inhibition for up to 24 h is well tolerated, longer exposure to the inhibitor induces apoptosis in tumor cells, suggesting that selective CDK1 inhibitors may have utility in cancer therapy.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Replication stress and cancer.

              Genome instability is a hallmark of cancer, and DNA replication is the most vulnerable cellular process that can lead to it. Any condition leading to high levels of DNA damage will result in replication stress, which is a source of genome instability and a feature of pre-cancerous and cancerous cells. Therefore, understanding the molecular basis of replication stress is crucial to the understanding of tumorigenesis. Although a negative aspect of replication stress is its prominent role in tumorigenesis, a positive aspect is that it provides a potential target for cancer therapy. In this Review, we discuss the link between persistent replication stress and tumorigenesis, with the goal of shedding light on the mechanisms underlying the initiation of an oncogenic process, which should open up new possibilities for cancer diagnostics and treatment.
                Bookmark

                Author and article information

                Contributors
                Journal
                Cell Rep
                Cell Rep
                Cell Reports
                Cell Press
                2211-1247
                19 April 2022
                19 April 2022
                19 April 2022
                : 39
                : 3
                : 110701
                Affiliations
                [1 ]Chromosome Dynamics and Stability Group, Genome Damage and Stability Centre, University of Sussex, Brighton BN1 9RQ, UK
                Author notes
                []Corresponding author koklung.chan@ 123456sussex.ac.uk
                [2]

                Present address: The Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Rd, Chelsea, London SW3 6JB, UK

                [3]

                These authors contributed equally

                [4]

                Lead contact

                Article
                S2211-1247(22)00459-4 110701
                10.1016/j.celrep.2022.110701
                9226383
                35443178
                96bb973e-1a58-4d42-aa93-2c69f54985df
                © 2022 The Authors

                This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

                History
                : 13 April 2021
                : 21 December 2021
                : 28 March 2022
                Categories
                Report

                Cell biology
                midas,g2 dna synthesis,s-to-m dna synthesis runover,ro3306,cdk1 inhibition,atr-mediated replication checkpoint,mild replication stress,aphidicolin,rad51,rad52

                Comments

                Comment on this article